(Q46375237)

21 December 2017

title

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia (English)

1 reference

21 December 2017

0 references

J B Weinberg

1

1 reference

21 December 2017

A D Volkheimer

2

1 reference

21 December 2017

M Mihovilovic

3

1 reference

21 December 2017

N Jiang

4

1 reference

21 December 2017

Y Chen

5

1 reference

21 December 2017

K Bond

6

1 reference

21 December 2017

J O Moore

7

1 reference

21 December 2017

J P Gockerman

8

1 reference

21 December 2017

L F Diehl

9

1 reference

21 December 2017

C M de Castro

10

1 reference

21 December 2017

D A Rizzieri

11

1 reference

21 December 2017

M C Levesque

12

1 reference

21 December 2017

R Dekroon

13

1 reference

21 December 2017

W J Strittmatter

14

1 reference

21 December 2017

publication date

11 September 2008

1 reference

21 December 2017

published in

Leukemia

1 reference

21 December 2017

volume

22

1 reference

21 December 2017

issue

12

1 reference

21 December 2017

page(s)

2184-2192

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2008.241

exact match

0 references

cites work

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

Chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt Pathway via the phosphoinositol phosphatase SHIP2

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

ApoE genotype-specific inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Apolipoprotein E and atherosclerosis: insight from animal and human studies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Sex differences in incidence and outcome of chronic lymphocytic leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Superoxide dismutase as a target for the selective killing of cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol: correlation of response to the in vitro synthesis of RNA by patient lymphocytes and its relationship to tr

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Androgens protect against apolipoprotein E4-induced cognitive deficits

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.241

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.241

1 reference

21 December 2017

1 reference

21 December 2017